Anduril, founded by Oculus creator Palmer Luckey, is positioning itself to be a key player in President Trump's "Golden Dome" project.

A 69-metre long rounded LED structure featuring content that responds dynamically to passenger flow has been installed at ...

For a good VR experience with the Oculus Rift, your PC needs to meet certain standards, especially for the graphics card and ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced ...

First registrational study to specifically evaluate a targeted treatment for patients living with ocular MGResults support planned Supplemental Biologics License Application (sBLA) submission to ...

Efgartigimod led to statistically significant improvement in key symptoms of ocular myasthenia gravis compared with placebo in a phase 3 trial.

X recently announced results from additional analyses of its blockbuster FcRn inhibitor Vyvgart in the phase III Adapt Oculus study. The study evaluated the efficacy and safety of Vyvgart administered ...

Anduril Industries announced on Wednesday that it is acquiring ExoAnalytic Solutions, a space intelligence firm that operates a vast network of sensors monitoring the veiled movements of satellites ...

Positive results from Phase 3 ADAPT OCULUS study show VYVGART’s potential as the first targeted treatment for patients ...

Results from ADAPT OCULUS are expected to support a sBLA submission to the FDA to secure a label expansion for oMG.

Netherlands-based immunology company argenx has announced positive topline results from the Phase III ADAPT OCULUS study of Vyvgart (efgartigimod alfa and hyaluronidase-qvfc) in adults with ocular ...

Three manatees are ready to make their debut in a new Jacksonville Zoo and Botanical Gardens exhibit. Here's a preview.